FDA Orange Book · active-ingredient family
Acetaminophen; tramadol hydrochloride
Acetaminophen; tramadol hydrochloride is approved as 1 brand and 11 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:ULTRACET · NDA 021123
1
Brand (NDA)
11
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ULTRACETRLD | JANSSEN PHARMS | NDA 021123 | — | Aug 15, 2001 |
Generic (ANDA) products (11)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | MACLEODS PHARMS LTD | ANDA 206885 | — | May 02, 2017 | |
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | AUROBINDO PHARMA | ANDA 207152 | AB | Mar 22, 2017 | |
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | MPP PHARMA | ANDA 078778 | — | Apr 07, 2014 | |
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | MICRO LABS LTD INDIA | ANDA 201952 | AB | Dec 14, 2012 | |
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | ZYDUS PHARMS USA INC | ANDA 090460 | AB | Sep 06, 2012 | |
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | ALKEM LABS LTD | ANDA 202076 | AB | Mar 30, 2012 | |
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | AMNEAL PHARMS | ANDA 090485 | AB | Dec 09, 2009 | |
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | RISING | ANDA 077858 | AB | Sep 26, 2008 | |
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | GRAVITI PHARMS | ANDA 076914 | — | Jul 26, 2006 | |
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | SUN PHARM INDS INC | ANDA 077184 | — | Dec 16, 2005 | |
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | CHARTWELL RX | ANDA 076475 | — | Apr 21, 2005 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Acetaminophen; tramadol hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

